Evaluation of Newborns Presenting With Suspected COVID 19

Official Title

Evaluation of Newborns Presenting With Suspected COVID 19: A Single Center Experience

Brief Summary

This study evaluates the newborns who had respiratory symptoms at the neonatal intensive care admission

Status

Unknown status

Conditions

Viral Infection

Eligibility Criteria

Inclusion Criteria:

- All newborns who had respiratory symptoms at the NICU admission

Exclusion Criteria:

- Congenital abnormalities

Eligibility Gender

All

Eligibility Age

Minimum: N/A ~ Maximum: 1 Month

Countries

Turkey

Locations

İzmir Dr. Behcet Uz Training and Research Hospital
İzmir, Turkey

NCT Number

NCT04519307

Keywords

newborn

COVID infection

Viral Infection

MeSH Terms

Infections

Virus Diseases

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Dr. Behcet Uz Children's Hospital

Evaluation of Newborns Presenting With Suspected COVID 19

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA